Chidamide: Exploration of maintenance therapy for patients with DLBCL with HBV infection.

iScience · 2026 · PMC12800633 · PMID 41541686

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a favorable trendno p-value reported

Although no significant difference in OS was observed, the chidamide group showed a favorable trend.

also in 993 other papers

showed a trendno p-value reported

Although no significant difference was observed between the two groups ( p = 0.112), the HBV − DLBCL group showed a trend toward better PFS outcomes.

also in 33,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.